Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Foley

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Veterinary Parasitology|August 18, 2011
Comparison of diagnostic methods to detect piroplasms in asymptomatic cattleR Galuppi, C Bonoli, S Aureli, et al.
Diabetes, Obesity & Metabolism|August 14, 2012
Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in manS J Busch, P Hoffmann, P Sahota, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
Presentation of a new method for specific measurement of in vivo insulin-stimulated glucose disposal in humans: comparison of this approach with the insulin clamp and minimal model techniquesC C Donner, E Fraze, Y D Chen, et al.
Diabetes, Obesity & Metabolism|February 6, 2008
Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*W A Scherbaum, A Schweizer, A Mari, et al.
The American Journal of Physiology|March 1, 1984
Sex difference in insulin-stimulated glucose transport in rat and human adipocytesJ E Foley, A Kashiwagi, H Chang, et al.
Diabetologia|May 3, 2013
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse modelB A Omar, J Vikman, M S Winzell, et al.
Metabolism: Clinical and Experimental|August 1, 1984
In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima Indians with normal glucose toleranceA Kashiwagi, C Bogardus, S Lillioja, et al.
The Journal of Biological Chemistry|March 29, 2001
alpha 1(Xx) collagen, a new member of the collagen subfamily, fibril-associated collagens with interrupted triple helicesM Koch, J E Foley, R Hahn, et al.
Diabetes, Obesity & Metabolism|July 24, 2010
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year studyD R Matthews, S Dejager, B Ahren, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 18, 2008
Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trialC Pan, W Yang, J P Barona, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Veterinary Parasitology|August 18, 2011
Comparison of diagnostic methods to detect piroplasms in asymptomatic cattleR Galuppi, C Bonoli, S Aureli, et al.
Diabetes, Obesity & Metabolism|August 14, 2012
Studies in rodents with the dipeptidyl peptidase-4 inhibitor vildagliptin to evaluate possible drug-induced pancreatic histological changes that are predictive of pancreatitis and cancer development in manS J Busch, P Hoffmann, P Sahota, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1985
Presentation of a new method for specific measurement of in vivo insulin-stimulated glucose disposal in humans: comparison of this approach with the insulin clamp and minimal model techniquesC C Donner, E Fraze, Y D Chen, et al.
Diabetes, Obesity & Metabolism|February 6, 2008
Efficacy and tolerability of vildagliptin in drug-naïve patients with type 2 diabetes and mild hyperglycaemia*W A Scherbaum, A Schweizer, A Mari, et al.
The American Journal of Physiology|March 1, 1984
Sex difference in insulin-stimulated glucose transport in rat and human adipocytesJ E Foley, A Kashiwagi, H Chang, et al.
Diabetologia|May 3, 2013
Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse modelB A Omar, J Vikman, M S Winzell, et al.
Metabolism: Clinical and Experimental|August 1, 1984
In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima Indians with normal glucose toleranceA Kashiwagi, C Bogardus, S Lillioja, et al.
The Journal of Biological Chemistry|March 29, 2001
alpha 1(Xx) collagen, a new member of the collagen subfamily, fibril-associated collagens with interrupted triple helicesM Koch, J E Foley, R Hahn, et al.
Diabetes, Obesity & Metabolism|July 24, 2010
Vildagliptin add-on to metformin produces similar efficacy and reduced hypoglycaemic risk compared with glimepiride, with no weight gain: results from a 2-year studyD R Matthews, S Dejager, B Ahren, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 18, 2008
Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trialC Pan, W Yang, J P Barona, et al.
Pageof 15